Company Announcements
Director/PDMR Shareholding
Related Companies
By LSE RNS
Consort Medical plc (the 'Company')
Director/PDMR shareholding
21 June 2017
Consort Medical plc announces that a director and a person discharging managerial responsibilities ('PDMR') as detailed below, have exercised awards over ordinary shares in the Company ('Ordinary Shares') in accordance with the terms of the Consort Medical plc Deferred Bonus Plan (the 'DBP') and the Consort Medical Long-Term Incentive Plan (the 'LTIP') (together the 'Awards').
The Awards vested on 20 June 2017 pursuant to respective awards made on 20 June 2014 and were exercised for nil consideration by the individuals on 20 June 2017.
The exercise of the Awards was satisfied out of the Ordinary Shares held in the Consort Medical plc Employee Share Ownership Trust.
Also on 20 June 2017, the same director and PDMR below disposed of Ordinary Shares at £10.76 per share, with part of the net proceeds of the disposals used to cover the tax liabilities associated to the exercise of the Awards. The relevant director's and PDMR's resultant interests in the Ordinary Shares of the Company remained unchanged as a result of the transactions.
|
Individual |
Director /PDMR |
Ordinary Shares exercised under the DBP |
Ordinary Shares exercised under the LTIP |
Total Ordinary Shares exercised
|
Total Ordinary Shares sold
|
Total resultant Ordinary Shares held |
% of Ordinary Share capital held |
|
Jonathan Glenn |
Director |
17,373 |
60,276 |
77,649 |
77,649 |
151,211 |
0.31 |
|
Keyvan Djamarani |
PDMR |
5,121 |
22,600 |
27,721 |
27,721 |
21,416 |
0.04 |
The Company was informed of the above transactions by the Consort Medical Employee Share Ownership Trust on 20 June 2017.
Mr Glenn's residual shareholding of 151,211 equates to a 3.36 multiple of salary (calculated using the exercise share price of £10.76 per share).
Enquiries: Michelle Palmer Assistant Company Secretary 01442 867920
|
1
|
Details of the person discharging managerial responsibilities / person closely associated
|
||||
|
a)
|
Name
|
Jonathan Glenn |
|||
|
2
|
Reason for the notification
|
||||
|
a)
|
Position/status
|
CEO |
|||
|
b)
|
Initial notification /Amendment
|
Initial |
|||
|
3
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
||||
|
a)
|
Name
|
Consort Medical plc |
|||
|
b)
|
LEI
|
2138001TBP74FD66QT38 |
|||
|
4
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
||||
|
a)
|
Description of the financial instrument, type of instrument |
Ordinary 10p shares |
|||
|
|
|
||||
|
Identification code |
ISIN: GB0000946276 |
||||
|
|
|
||||
|
b)
|
Nature of the transaction
|
Exercise of Deferred Bonus Plan and Long Term Incentive Plan shares |
|||
|
c)
|
Price(s) and volume(s) |
|
|
|
|
|
|
|
Price(s) |
Volume(s) |
|
|
|
|
|
0 |
77,649 |
|
|
|
|
|
|
|
|
|
|
d)
|
Aggregated information |
|
|||
|
|
n/a single transaction |
||||
|
- Aggregated volume |
|
||||
|
|
|
||||
|
- Price |
|
||||
|
|
|
||||
|
e)
|
Date of the transaction
|
20 June 2017 |
|||
|
f)
|
Place of the transaction
|
Off market transaction |
|||
|
1
|
Details of the person discharging managerial responsibilities / person closely associated
|
||||
|
a)
|
Name
|
Jonathan Glenn |
|||
|
2
|
Reason for the notification
|
||||
|
a)
|
Position/status
|
CEO |
|||
|
b)
|
Initial notification /Amendment
|
Initial |
|||
|
3
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
||||
|
a)
|
Name
|
Consort Medical plc |
|||
|
b)
|
LEI
|
2138001TBP74FD66QT38 |
|||
|
4
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
||||
|
a)
|
Description of the financial instrument, type of instrument |
Ordinary 10p shares |
|||
|
|
|
||||
|
Identification code |
ISIN: GB0000946276 |
||||
|
|
|
||||
|
b)
|
Nature of the transaction
|
Sale of Deferred Bonus Plan and Long Term Incentive Plan shares with part of the sale being used to cover the Tax and NI liabilities associated with the exercise of the Awards |
|||
|
c)
|
Price(s) and volume(s) |
|
|
|
|
|
|
|
Price(s) |
Volume(s) |
|
|
|
|
|
10.76 |
77,649 |
|
|
|
|
|
|
|
|
|
|
d)
|
Aggregated information |
|
|||
|
|
n/a single transaction |
||||
|
- Aggregated volume |
|
||||
|
|
|
||||
|
- Price |
|
||||
|
|
|
||||
|
e)
|
Date of the transaction |
20 June 2017 |
|||
|
f)
|
Place of the transaction
|
Off market transaction |
|||
|
1
|
Details of the person discharging managerial responsibilities / person closely associated
|
||||
|
a)
|
Name
|
Keyvan Djamarani |
|||
|
2
|
Reason for the notification
|
||||
|
a)
|
Position/status
|
Managing Director Bespak Division |
|||
|
b)
|
Initial notification /Amendment
|
Initial |
|||
|
3
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
||||
|
a)
|
Name
|
Consort Medical plc |
|||
|
b)
|
LEI
|
2138001TBP74FD66QT38 |
|||
|
4
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
||||
|
a)
|
Description of the financial instrument, type of instrument |
Ordinary 10p shares |
|||
|
|
|
||||
|
Identification code |
ISIN: GB0000946276 |
||||
|
|
|
||||
|
b)
|
Nature of the transaction
|
Exercise of Deferred Bonus Plan and Long Term Incentive Plan shares |
|||
|
c)
|
Price(s) and volume(s) |
|
|
|
|
|
|
|
Price(s) |
Volume(s) |
|
|
|
|
|
0 |
27,721 |
|
|
|
|
|
|
|
|
|
|
d)
|
Aggregated information |
|
|||
|
|
n/a single transaction |
||||
|
- Aggregated volume |
|
||||
|
|
|
||||
|
- Price |
|
||||
|
|
|
||||
|
e)
|
Date of the transaction
|
20 June 2017 |
|||
|
f)
|
Place of the transaction
|
Off market transaction |
|||
|
1
|
Details of the person discharging managerial responsibilities / person closely associated
|
||||
|
a)
|
Name
|
Keyvan Djamarani |
|||
|
2
|
Reason for the notification
|
||||
|
a)
|
Position/status
|
Managing Director Bespak Division |
|||
|
b)
|
Initial notification /Amendment
|
Initial |
|||
|
3
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
||||
|
a)
|
Name
|
Consort Medical plc |
|||
|
b)
|
LEI
|
2138001TBP74FD66QT38 |
|||
|
4
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
||||
|
a)
|
Description of the financial instrument, type of instrument |
Ordinary 10p shares |
|||
|
|
|
||||
|
Identification code |
ISIN: GB0000946276 |
||||
|
|
|
||||
|
b)
|
Nature of the transaction
|
Sale of Deferred Bonus Plan and Long Term Incentive Plan shares with part of the sale being used to cover the Tax and NI liabilities associated with the exercise of the Awards |
|||
|
c)
|
Price(s) and volume(s) |
|
|
|
|
|
|
|
Price(s) |
Volume(s) |
|
|
|
|
|
10.76 |
27,721 |
|
|
|
|
|
|
|
|
|
|
d)
|
Aggregated information |
|
|||
|
|
n/a single transaction |
||||
|
- Aggregated volume |
|
||||
|
|
|
||||
|
- Price |
|
||||
|
|
|
||||
|
e)
|
Date of the transaction |
20 June 2017 |
|||
|
f)
|
Place of the transaction
|
Off market transaction |
|||
This information is provided by RNS
You are here: news > regulatory news
10 Lower Thames St,
London EC3R 6EN